Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment

A brain tumor is an uncontrolled cell proliferation, a mass of tissue composed of cells that grow and divide abnormally and appear to be uncontrollable by the processes that normally control normal cells. Approximately 25,690 primary malignant brain tumors are discovered each year, 70% of which orig...

Full description

Bibliographic Details
Main Authors: Monika Kaurav, Sakina Ruhi, Husni Ahmed Al-Goshae, Ashok Kumar Jeppu, Dhani Ramachandran, Ram Kumar Sahu, Ashish Kumar Sarkar, Jiyauddin Khan, Abu Md Ashif Ikbal
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1159131/full
_version_ 1827989176831705088
author Monika Kaurav
Monika Kaurav
Sakina Ruhi
Husni Ahmed Al-Goshae
Ashok Kumar Jeppu
Dhani Ramachandran
Ram Kumar Sahu
Ashish Kumar Sarkar
Jiyauddin Khan
Abu Md Ashif Ikbal
author_facet Monika Kaurav
Monika Kaurav
Sakina Ruhi
Husni Ahmed Al-Goshae
Ashok Kumar Jeppu
Dhani Ramachandran
Ram Kumar Sahu
Ashish Kumar Sarkar
Jiyauddin Khan
Abu Md Ashif Ikbal
author_sort Monika Kaurav
collection DOAJ
description A brain tumor is an uncontrolled cell proliferation, a mass of tissue composed of cells that grow and divide abnormally and appear to be uncontrollable by the processes that normally control normal cells. Approximately 25,690 primary malignant brain tumors are discovered each year, 70% of which originate in glial cells. It has been observed that the blood-brain barrier (BBB) limits the distribution of drugs into the tumour environment, which complicates the oncological therapy of malignant brain tumours. Numerous studies have found that nanocarriers have demonstrated significant therapeutic efficacy in brain diseases. This review, based on a non-systematic search of the existing literature, provides an update on the existing knowledge of the types of dendrimers, synthesis methods, and mechanisms of action in relation to brain tumours. It also discusses the use of dendrimers in the diagnosis and treatment of brain tumours and the future possibilities of dendrimers. Dendrimers are of particular interest in the diagnosis and treatment of brain tumours because they can transport biochemical agents across the BBB to the tumour and into the brain after systemic administration. Dendrimers are being used to develop novel therapeutics such as prolonged release of drugs, immunotherapy, and antineoplastic effects. The use of PAMAM, PPI, PLL and surface engineered dendrimers has proven revolutionary in the effective diagnosis and treatment of brain tumours.
first_indexed 2024-04-10T00:15:13Z
format Article
id doaj.art-2cd4210bf8af4f7aba7a9439df959ed8
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-10T00:15:13Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-2cd4210bf8af4f7aba7a9439df959ed82023-03-16T05:16:21ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-03-011410.3389/fphar.2023.11591311159131Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatmentMonika Kaurav0Monika Kaurav1Sakina Ruhi2Husni Ahmed Al-Goshae3Ashok Kumar Jeppu4Dhani Ramachandran5Ram Kumar Sahu6Ashish Kumar Sarkar7Jiyauddin Khan8Abu Md Ashif Ikbal9Department of Pharmaceutics, KIET Group of Institutions (KIET School of Pharmacy), Delhi NCR, Ghaziabad, IndiaDr. A.P.J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh, IndiaDepartment of Biochemistry, IMS, Management and Science University, University Drive, Shah Alam, Selangor, MalaysiaDepartment of Anantomy, IMS, Management and Science University, University Drive, Shah Alam, Selangor, MalaysiaDepartment of Biochemistry, IMS, Management and Science University, University Drive, Shah Alam, Selangor, MalaysiaDepartment of Pathology, IMS, Management and Science University, University Drive, Shah Alam, Selangor, MalaysiaDepartment of Pharmaceutical Sciences, Hemvati Nandan Bahuguna Garhwal University (A Central University), Chauras Campus, Tehri Garhwal, Uttarakhand, IndiaSchool of Pharmacy, YBN University, Ranchi, Jharkhand, IndiaSchool of Pharmacy, Management and Science University, Shah Alam, Selangor, MalaysiaDepartment of Pharmaceutical Sciences, Assam University (A Central University), Silchar, Assam, IndiaA brain tumor is an uncontrolled cell proliferation, a mass of tissue composed of cells that grow and divide abnormally and appear to be uncontrollable by the processes that normally control normal cells. Approximately 25,690 primary malignant brain tumors are discovered each year, 70% of which originate in glial cells. It has been observed that the blood-brain barrier (BBB) limits the distribution of drugs into the tumour environment, which complicates the oncological therapy of malignant brain tumours. Numerous studies have found that nanocarriers have demonstrated significant therapeutic efficacy in brain diseases. This review, based on a non-systematic search of the existing literature, provides an update on the existing knowledge of the types of dendrimers, synthesis methods, and mechanisms of action in relation to brain tumours. It also discusses the use of dendrimers in the diagnosis and treatment of brain tumours and the future possibilities of dendrimers. Dendrimers are of particular interest in the diagnosis and treatment of brain tumours because they can transport biochemical agents across the BBB to the tumour and into the brain after systemic administration. Dendrimers are being used to develop novel therapeutics such as prolonged release of drugs, immunotherapy, and antineoplastic effects. The use of PAMAM, PPI, PLL and surface engineered dendrimers has proven revolutionary in the effective diagnosis and treatment of brain tumours.https://www.frontiersin.org/articles/10.3389/fphar.2023.1159131/fulldendrimersbrain tumorbrain tumor imagingbrain targetingtheranostics
spellingShingle Monika Kaurav
Monika Kaurav
Sakina Ruhi
Husni Ahmed Al-Goshae
Ashok Kumar Jeppu
Dhani Ramachandran
Ram Kumar Sahu
Ashish Kumar Sarkar
Jiyauddin Khan
Abu Md Ashif Ikbal
Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment
Frontiers in Pharmacology
dendrimers
brain tumor
brain tumor imaging
brain targeting
theranostics
title Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment
title_full Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment
title_fullStr Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment
title_full_unstemmed Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment
title_short Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment
title_sort dendrimer an update on recent developments and future opportunities for the brain tumors diagnosis and treatment
topic dendrimers
brain tumor
brain tumor imaging
brain targeting
theranostics
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1159131/full
work_keys_str_mv AT monikakaurav dendrimeranupdateonrecentdevelopmentsandfutureopportunitiesforthebraintumorsdiagnosisandtreatment
AT monikakaurav dendrimeranupdateonrecentdevelopmentsandfutureopportunitiesforthebraintumorsdiagnosisandtreatment
AT sakinaruhi dendrimeranupdateonrecentdevelopmentsandfutureopportunitiesforthebraintumorsdiagnosisandtreatment
AT husniahmedalgoshae dendrimeranupdateonrecentdevelopmentsandfutureopportunitiesforthebraintumorsdiagnosisandtreatment
AT ashokkumarjeppu dendrimeranupdateonrecentdevelopmentsandfutureopportunitiesforthebraintumorsdiagnosisandtreatment
AT dhaniramachandran dendrimeranupdateonrecentdevelopmentsandfutureopportunitiesforthebraintumorsdiagnosisandtreatment
AT ramkumarsahu dendrimeranupdateonrecentdevelopmentsandfutureopportunitiesforthebraintumorsdiagnosisandtreatment
AT ashishkumarsarkar dendrimeranupdateonrecentdevelopmentsandfutureopportunitiesforthebraintumorsdiagnosisandtreatment
AT jiyauddinkhan dendrimeranupdateonrecentdevelopmentsandfutureopportunitiesforthebraintumorsdiagnosisandtreatment
AT abumdashifikbal dendrimeranupdateonrecentdevelopmentsandfutureopportunitiesforthebraintumorsdiagnosisandtreatment